Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TVT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Presenter: Patrick W. Serruys

June 16, 2017

Presentation TVT 2017

The Self-Expanding Single-Operator CENTERA TAVR System

Presenter: Didier Tchetche

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 16, 2017

Presentation TVT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Hendrik Treede

June 16, 2017

Presentation TVT 2017

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Presenter: John K. Forrest, James M. McCabe, Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

Inadequate Femoral Access All Roads Lead to Rome

Presenter: John K. Forrest, James M. McCabe, Adam B. Greenbaum

June 16, 2017

Presentation TVT 2017

Sizing in the Gray Zone

Presenter: John K. Forrest, James M. McCabe, Christopher U. Meduri

June 16, 2017

Presentation TVT 2017

Hard as Rock Calcium Annulus and LOVT Scenarios

Presenter: John K. Forrest, James M. McCabe, Kendra J. Grubb

June 16, 2017

Presentation TVT 2017

Extreme East-West (Horizontal) Aorta

Presenter: John K. Forrest, James M. McCabe, Saif Anwaruddin

June 16, 2017

Presentation TVT 2017

How Many TAVR Systems Are Needed in a Busy TAVR Program?

Presenter: Ganesh Manoharan, Hendrik Treede, Axel Linke

June 16, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Presentation TVT 2017

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Martin B. Leon, Philippe Généreux

June 15, 2017

Presentation TVT 2017

4C Valve: A Novel Transcatheter MR Treatment Technology

Presenter: Juan F. Granada, Martin B. Leon, Gregg W. Stone, Philippe Généreux

June 14, 2017

Advertisement

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

The Self-Expanding Single-Operator CENTERA TAVR System

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

The Venus A-Valve and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Threatened Left Main Avoid, Pre-Emptive Planning, or React as Needed

Inadequate Femoral Access All Roads Lead to Rome

Sizing in the Gray Zone

Hard as Rock Calcium Annulus and LOVT Scenarios

Extreme East-West (Horizontal) Aorta

How Many TAVR Systems Are Needed in a Busy TAVR Program?

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

4C Valve: A Novel Transcatheter MR Treatment Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content